Stevee Krognes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Crestline Management LP lowered its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 5.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,660,732 shares of the company’s stock after selling 300,000 shares during the period. Denali Therapeutics makes up 10.3% of Crestline Management LP’s holdings, making the stock its biggest position. […]

Edmond DE Rothschild Holding S.A. grew its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 65.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 165,680 shares of the company’s stock after buying an additional 65,800 shares during the […]

Pier 88 Investment Partners LLC cut its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 10.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 45,240 shares of the company’s stock after selling 5,460 shares during the period. Pier 88 Investment Partners LLC’s […]

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.56 and last traded at $14.79, with a volume of 172121 shares changing hands. The stock had previously closed at $15.56. Analyst Ratings Changes DNLI has been the […]

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.56 and last traded at $14.79, with a volume of 172121 shares changing hands. The stock had previously closed at $15.56. Analyst Ratings Changes DNLI has been the […]